Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
An Otorrinolaringol Ibero Am ; 29(1): 53-9, 2002.
Artigo em Espanhol | MEDLINE | ID: mdl-11962002

RESUMO

Myoepithelioma of the salivary gland is a benign tumor set up almost exclusively for myoepithelial cells. It is considered as the terminal form of the histopathologic spectrum of mixed tumors, but owing to its monomorphic appearance is considered an aside form. In this article is reported one myoepithelial case of the parotid gland and are also reviewed the published literature of this sort of neoplasms.


Assuntos
Mioepitelioma/patologia , Neoplasias Parotídeas/patologia , Adulto , Feminino , Humanos
2.
Rev Esp Cardiol ; 47(10): 666-71, 1994 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-7991919

RESUMO

INTRODUCTION AND OBJECTIVES: Our aim was to evaluate the utility of thrombolytic therapy administered outside tertiary hospital. METHODS: We analyzed 80 consecutive patients with acute myocardial infarction admitted to the emergency area of primary hospital within 24 hours after the onset of symptoms and lastly transported to a coronary care unit (CCU) of a reference hospital. The thrombolytic protocol was performed by medicine department of primary hospital and the CCU of reference hospital. RESULTS: 23 patients without (group A) and 57 with (group B) fibrinolytic therapy (APSAC 50 patients and streptokinase 7 patients) were analyzed. Group A patient were older (mean: 67 +/- 11 vs mean: 62 +/- 10 years; p = 0.01), and arrived later to emergency area (mean 254 +/- 284 vs mean 163 SD 161 min; p = 0.04) and to the coronary care unit (mean 561 +/- 371 vs mean 334 +/- 177 min; p = 0.0002). The guard physician decision to start or not the fibrinolytic therapy, was adequate in 86% of the patients (sensitivity 87%, predictive positive value 95%, specificity 83%). Complications on emergency area or during transport in group B were ventricular fibrillation in 9%, AV block (2-3 degree) in 9%, severe nonsustained ventricular arrhythmia in 11% and transitory hypotension in 23%. No death occurred before CCU admission. In group B, 35% patients was treated within the first 2 hours. The average time gain was 124 min (thrombolysis administration--CCU admission). CONCLUSION: On emergency area of primary hospital, thrombolytic therapy is feasible and safe when administered by well-equipped and well-trained medical emergence area and ambulance staff.


Assuntos
Anistreplase/administração & dosagem , Unidades de Cuidados Coronarianos , Infarto do Miocárdio/tratamento farmacológico , Terapia Trombolítica/efeitos adversos , Idoso , Emergências , Feminino , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Segurança , Espanha , Terapia Trombolítica/métodos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...